Simone Bier, Anton Wolff, Michael Zitzmann, Sabine Kliesch
{"title":"不育夫妇中无精子男性:早期医学诊断程序的潜在益处。","authors":"Simone Bier, Anton Wolff, Michael Zitzmann, Sabine Kliesch","doi":"10.1111/andr.70035","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Infertility, defined as the inability to achieve pregnancy despite regular, unprotected sexual intercourse for 1 year, affects approximately 15% of couples. Male factors contribute to 50% of these cases. The necessity of andrological evaluations for male partners of infertile couples with normozoospermia is currently under consideration.</p><p><strong>Methods: </strong>From 2010 to 2020, our center evaluated 997 patients presenting with infertility and normozoospermia. All patients underwent comprehensive assessments, including physical examinations, testicular sonography, blood tests, follice-stimulating hormone beta (FSHB) c.-211 variants, and semen analyses. For comparative purposes, we established two control groups: one comprising healthy men participating in the FAMe study (n = 201) and another consisting of men seeking fertility restoration following vasectomy (n = 75). Within the infertile male group, we further stratified patients into those with primary or secondary infertility.</p><p><strong>Results: </strong>Analysis of patient histories revealed a significantly elevated prevalence of genital malformations (e.g., hypospadias (p = 0.024) and undescended testes during childhood (p < 0.001) in our infertile group relative to the control group. By anamnesis we could find significant more patients with erectile dysfunction (p < 0.001) in our infertile men. The physical examination showed significant more patients with obesity in our infertility group (p < 0.001). Regarding hormonal profiles, a notably higher proportion of patients in the infertility group exhibited hypogonadism (p < 0.001), while compensated hypogonadism was more common in the control group. Reduced serum follicle-stimulating hormone (FSH) concentrations in men with the FSHB c.-211 GT/TT polymorphism versus the GG wildtype were only present in the infertile but not the fertile cohort (p < 0.001). Evaluation of ejaculate samples indicated a significant increase in round cells (p < 0.001) and leukocytes (p = 0.013) in our infertile patients compared to the healthy subjects.</p><p><strong>Discussion: </strong>The assessment of men presenting with infertility and normozoospermia unveiled a marked prevalence of physical and genetic findings. This underscores the critical need for andrological evaluations to prevent potential long-term consequences.</p><p><strong>Conclusion: </strong>The andrological examination of normozoospermic and infertile men promises better health outcomes for the patients as well as it aids in refining fertility treatment options for their female counterparts.</p>","PeriodicalId":7898,"journal":{"name":"Andrology","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Normozoospermic men in infertile couples: Potential benefit of early medical diagnostic procedures.\",\"authors\":\"Simone Bier, Anton Wolff, Michael Zitzmann, Sabine Kliesch\",\"doi\":\"10.1111/andr.70035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Infertility, defined as the inability to achieve pregnancy despite regular, unprotected sexual intercourse for 1 year, affects approximately 15% of couples. Male factors contribute to 50% of these cases. The necessity of andrological evaluations for male partners of infertile couples with normozoospermia is currently under consideration.</p><p><strong>Methods: </strong>From 2010 to 2020, our center evaluated 997 patients presenting with infertility and normozoospermia. All patients underwent comprehensive assessments, including physical examinations, testicular sonography, blood tests, follice-stimulating hormone beta (FSHB) c.-211 variants, and semen analyses. For comparative purposes, we established two control groups: one comprising healthy men participating in the FAMe study (n = 201) and another consisting of men seeking fertility restoration following vasectomy (n = 75). Within the infertile male group, we further stratified patients into those with primary or secondary infertility.</p><p><strong>Results: </strong>Analysis of patient histories revealed a significantly elevated prevalence of genital malformations (e.g., hypospadias (p = 0.024) and undescended testes during childhood (p < 0.001) in our infertile group relative to the control group. By anamnesis we could find significant more patients with erectile dysfunction (p < 0.001) in our infertile men. The physical examination showed significant more patients with obesity in our infertility group (p < 0.001). Regarding hormonal profiles, a notably higher proportion of patients in the infertility group exhibited hypogonadism (p < 0.001), while compensated hypogonadism was more common in the control group. Reduced serum follicle-stimulating hormone (FSH) concentrations in men with the FSHB c.-211 GT/TT polymorphism versus the GG wildtype were only present in the infertile but not the fertile cohort (p < 0.001). Evaluation of ejaculate samples indicated a significant increase in round cells (p < 0.001) and leukocytes (p = 0.013) in our infertile patients compared to the healthy subjects.</p><p><strong>Discussion: </strong>The assessment of men presenting with infertility and normozoospermia unveiled a marked prevalence of physical and genetic findings. This underscores the critical need for andrological evaluations to prevent potential long-term consequences.</p><p><strong>Conclusion: </strong>The andrological examination of normozoospermic and infertile men promises better health outcomes for the patients as well as it aids in refining fertility treatment options for their female counterparts.</p>\",\"PeriodicalId\":7898,\"journal\":{\"name\":\"Andrology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Andrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/andr.70035\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ANDROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Andrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/andr.70035","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANDROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
导读:不孕症的定义是尽管有规律的、无保护的性交1年仍无法怀孕,影响了大约15%的夫妇。男性因素占这些病例的50%。目前正在考虑对患有正常精子症的不育夫妇的男性伴侣进行男科评估的必要性。方法:2010年至2020年,本中心对997例不孕症和无精子症患者进行评估。所有患者都接受了全面的评估,包括体格检查、睾丸超声检查、血液检查、促卵泡激素β (FSHB) c -211变异和精液分析。为了比较,我们建立了两个对照组:一组由参与FAMe研究的健康男性组成(n = 201),另一组由输精管切除术后寻求恢复生育能力的男性组成(n = 75)。在不育男性组中,我们进一步将患者分为原发性和继发性不育。结果:对患者病史的分析显示,儿童期生殖器畸形(如尿道下裂(p = 0.024)和睾丸隐睾的患病率显著升高(p)。讨论:对男性不育症和正常精子症的评估揭示了生理和遗传方面的显著患病率。这强调了对男科评估的迫切需要,以防止潜在的长期后果。结论:对精子正常和不育的男性进行男科检查,可以为患者带来更好的健康结果,并有助于改善女性的生育治疗选择。
Normozoospermic men in infertile couples: Potential benefit of early medical diagnostic procedures.
Introduction: Infertility, defined as the inability to achieve pregnancy despite regular, unprotected sexual intercourse for 1 year, affects approximately 15% of couples. Male factors contribute to 50% of these cases. The necessity of andrological evaluations for male partners of infertile couples with normozoospermia is currently under consideration.
Methods: From 2010 to 2020, our center evaluated 997 patients presenting with infertility and normozoospermia. All patients underwent comprehensive assessments, including physical examinations, testicular sonography, blood tests, follice-stimulating hormone beta (FSHB) c.-211 variants, and semen analyses. For comparative purposes, we established two control groups: one comprising healthy men participating in the FAMe study (n = 201) and another consisting of men seeking fertility restoration following vasectomy (n = 75). Within the infertile male group, we further stratified patients into those with primary or secondary infertility.
Results: Analysis of patient histories revealed a significantly elevated prevalence of genital malformations (e.g., hypospadias (p = 0.024) and undescended testes during childhood (p < 0.001) in our infertile group relative to the control group. By anamnesis we could find significant more patients with erectile dysfunction (p < 0.001) in our infertile men. The physical examination showed significant more patients with obesity in our infertility group (p < 0.001). Regarding hormonal profiles, a notably higher proportion of patients in the infertility group exhibited hypogonadism (p < 0.001), while compensated hypogonadism was more common in the control group. Reduced serum follicle-stimulating hormone (FSH) concentrations in men with the FSHB c.-211 GT/TT polymorphism versus the GG wildtype were only present in the infertile but not the fertile cohort (p < 0.001). Evaluation of ejaculate samples indicated a significant increase in round cells (p < 0.001) and leukocytes (p = 0.013) in our infertile patients compared to the healthy subjects.
Discussion: The assessment of men presenting with infertility and normozoospermia unveiled a marked prevalence of physical and genetic findings. This underscores the critical need for andrological evaluations to prevent potential long-term consequences.
Conclusion: The andrological examination of normozoospermic and infertile men promises better health outcomes for the patients as well as it aids in refining fertility treatment options for their female counterparts.
期刊介绍:
Andrology is the study of the male reproductive system and other male gender related health issues. Andrology deals with basic and clinical aspects of the male reproductive system (gonads, endocrine and accessory organs) in all species, including the diagnosis and treatment of medical problems associated with sexual development, infertility, sexual dysfunction, sex hormone action and other urological problems. In medicine, Andrology as a specialty is a recent development, as it had previously been considered a subspecialty of urology or endocrinology